Methoxyamine and Temozolomide in Treating Patients With Recurrent Glioblastoma
Clinical trial NCT02395692 · TERMINATED
Trial details
- NCT number
- NCT02395692
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-18
- Primary completion
- 2017-02-16
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.